Comparing the Effects of M-TAPA and TAP Block on Postoperative Analgesia in TAH
Launched by CUMHURIYET UNIVERSITY · Jun 12, 2023
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
There were three randomized groups: Group M (M-TAPA block) (n=15), Group T (TAP block) (n=15) and Group C (no block) (n=15). All patients had standard general anesthesia. Group M had bilateral M-TAPA block with 0.25% bupivacaine (total volume of 40 ml) at the end of the surgery. Group T patients had TAP block with 0.25% bupivacaine (total volume of 40 ml) at the end of the surgery. Group Control had only tramadol for postoperative pain. Numerical rating scale (NRS) was used to assess postoperative pain on 1st, 6th, 12th and 24th hour after the surgery. Total tramadol consumption was calcula...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult patients older than 35 years of age who underwent open total abdominal hysterectomy under general anesthesia and were American Society of Anesthesiologists (ASA) I-II-III according to the ASA risk classification.
- Exclusion Criteria:
- • Patients who did not give consent,
- • patients with coagulopathy,
- • patients with signs of infection at the block application site,
- • patients using anticoagulants,
- • patients with local anesthetic drug allergies,
- • patients undergoing laparoscopic surgery,
- • patients with unstable hemodynamics,
- • patients who could not cooperate during postoperative pain assessment
About Cumhuriyet University
Cumhuriyet University is a distinguished academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies that aim to enhance healthcare outcomes. With a focus on interdisciplinary collaboration, Cumhuriyet University fosters an environment conducive to rigorous scientific inquiry and ethical research practices, ensuring that trials conducted under its auspices adhere to the highest standards of quality and integrity. Through its dedicated efforts, the university contributes significantly to the global body of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sivas, , Turkey
Patients applied
Trial Officials
Oğuz Gündoğdu
Principal Investigator
Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported